Form 4: ResMed Global General Counsel Sells Shares Under Pre-Arranged Plan
Insider Transaction Report
ResMed's Global General Counsel, Michael J. Rider, sold 66 shares of common stock for $256.99 per share on July 1, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael J. Rider, Global General Counsel of ResMed Inc., reported a transaction involving company common stock.
- On July 1, 2025, Mr. Rider disposed of 66 shares of ResMed Common Stock.
- The shares were sold at a price of $256.99 per share.
- Following this transaction, Mr. Rider beneficially owns 8,536 shares of ResMed Common Stock directly.
- The transaction was executed under a Rule 10b5-1 trading plan, which was adopted on February 28, 2025.
Sentiment
Score: 5
Explanation: The document is a factual report of an insider stock transaction under a pre-arranged plan, which is neutral in sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Rule 10b5-1 plan adopted by Michael J. Rider. |
| 07/01/2025 | Transaction date for the sale of 66 shares of ResMed Common Stock. |
| 07/02/2025 | Date the Form 4 filing was signed and submitted. |
Keywords
ResMed, RMD, Insider Trading, Form 4, Stock Sale, Michael J. Rider, Global General Counsel, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.